The Vall d´Hebron Institute of Oncology (VHIO) Seeks a “Laboratory Technician”
Reference: Ref. 27-2021
Application deadline: 15/07/2021
Number of vacancies: 1
The Vall d´Hebron Institute of Oncology´s (VHIO) Prostate Cancer Translational Research Group, lead by Dr. Joaquin Mateo is recruiting a laboratory Technician specialised in research with animal models.
Our group focuses on studying and testing hypothesis-based targeted therapies in prostate cancer and we are especially committed to applying the potential clinical value of our findings to clinical trials. The successful candidate will form an integral part of the scientific team and support the execution of the group’s translational research program.
The selected candidate will be responsible for:
- Generation and maintenance of cell and patient-derived mouse xenografts
- Drug administration
- Collection and processing of tumors, blood and tissues of interest.
- Histology and cell culture tasks to provide support to other members of the group.
A very organized, motivated, team-oriented individual, who is highly skilled and experienced in working with animal models either in the academic or private sector. Specific experience in mouse models of cancer, drug administration and animal surgery will be highly valued.
Official accreditation for animal handling is mandatory
Prior experiencing in pursuing in-vivo experiments with mice models. Prior experience working with patient-derived cancer animal models will be highly considered.
Although not a mandatory requirement for the post, experience in other in other techniques such as histology (IHC/IF) and cell culture will be appreciated.
The position is open to candidates who want either a full-time or part-time job, as there is some flexibility for planning the tasks.
Salary will be estimated according to profile and experience.
Potential candidates should submit a curriculum vitae, letter of intent, and at least one reference via email to email@example.com, including the reference “Ref.27-2021” in the subject line of your email. Review of applications will commence immediately; interviews will be arranged with short-listed candidates.
Under the leadership of Josep Tabernero, the Vall d’Hebron Institute of Oncology (VHIO), has established itself as a comprehensive cancer center of proven excellence internationally. It is also thanks to VHIO’s optimal organizational structure based on a purely multidisciplinary and translational model that VHIO talents continue to anticipate and tackle the many unresolved questions in combatting this multifaceted and heterogeneous disease.
Located within the Vall d’Hebron Barcelona Hospital Campus, our researchers closely collaborate and interact with Vall d’Hebron physician-scientists. Translational science and clinical research are therefore tightly connected which promotes superb interaction and teamwork which, in turn, accelerates the bench-bedside-bed cycle of knowledge. This privileged environment affords VHIO direct access to patients as well as the entire spectrum of oncology professionals who care for them, and a second-to-none appreciation of how cancer science can translate into more powerful, targeted treatments and better practice for the care of patients.
VHIO’s pioneering model and programs, coupled with its belief in combining strengths through cross-border collaborations, continue to spur advances in reversing cancer resistance, halting metastatic spread, and more effectively treating even the most undruggable tumor types.
VHIO’s translation toward precision oncology: https://www.vhio.net
Vall d’Hebron Institute Oncology (VHIO) endorses the Requirements and Principles of the European Charter for Researchers, the Code of Conduct for the Recruitment of Researchers promoted by the European Commission and follows Equal Opportunities policies.
On 10th April 2018 VHIO was awarded the “HR Excellence in Research” logo. Our Institute was consequently granted permission to use the HR Excellence in Research Award logo as demonstration of its stimulating and favourable work environment in line with the Charter & Code.